Lanchi Ventures (formerly BlueRun Ventures China) is a leading early-stage venture capital firm headquartered in Beijing with offices in Singapore and Hong Kong. The firm focuses on AI, frontier tech, robotics, healthcare, and consumer startups across Asia.
They made 2 investments in the last 12 months. Average disclosed round size is $136.9M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
$560M
Top Stage
Seed
Last 12 Mo
3
Team
JT
Jui Tan
Managing Partner
TZ
Terry Zhu
Managing Partner
WC
Wei Cao
Partner
H(
Henry (Xiaoheng) Zhang
VP
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Tars | Seed | $455M | Jun 2026 |
 RockFlow | Unknown | — | Nov 2025 |
 Genspark | Series B | $275M | Nov 2025 |
 TCab Tech | Pre-Seed | $15M | Feb 2023 |
| 220n Bio | Seed | $3.3M | Dec 2021 |
| BBioheng Biotech Co., Ltd | Series B | $80M | Mar 2021 |
 TARS Robotics | Seed | $120M | — |
 ONERWAY | Series A | $10M | — |
Top Co-Investors
Decent Capital2 shared
Emergence Capital1 shared
LG Technology Ventures1 shared
UpHonest Capital1 shared
SBI Investment1 shared
Foresite Capital1 shared
GL Ventures1 shared
Shenzhen Capital Group1 shared
Acton Capital1 shared
Linear Capital1 shared
Meituan1 shared
Yunqi Partners1 shared
Last updated: 7 September 2026